{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:42:22Z","timestamp":1793378542443,"version":"4.5.0"},"reference-count":18,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"unspecified","delay-in-days":20,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2022,7,12]]},"published-print":{"date-parts":[[2022,7]]},"abstract":"<jats:p>Ventricular arrhythmias are a life-threatening factor in cardiac sarcoidosis (CS), posing a significant therapeutic challenge. Stellate ganglion phototherapy (SGP), a non-invasive procedure for modification of the sympathetic nervous system, is an effective treatment for refractory ventricular tachycardia (RVT). However, there are limited data on the efficacy of SGP for RVT in patients with CS. In our case report, we found that SGP was effective for treating RVT in a patient with CS.<\/jats:p>\n               <jats:p>We present the case of a man in his 60s with multiple cardioversions of implantable cardioverter defibrillator for ventricular tachycardia. The patient was administered prednisolone for the management of CS, which subsequently led to an increase in anti-tachycardia pacing for ventricular tachycardias. We introduced SGP to suppress RVT and anti-tachycardia pacing decreased from 371 to 25 events. Thus, SGP could be a feasible option for the management of RVT in patients with CS.<\/jats:p>","DOI":"10.1136\/bcr-2022-249183","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T11:30:52Z","timestamp":1658403052000},"page":"e249183","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":4,"title":["Successful use of stellate ganglion phototherapy in refractory ventricular tachycardia in a patient with cardiac sarcoidosis"],"prefix":"10.1136","volume":"15","author":[{"given":"Subaru","family":"Tanabe","sequence":"first","affiliation":[{"name":"Department of Cardiology, Aichi Medical University, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9314-3427","authenticated-orcid":false,"given":"Yusuke","family":"Nakano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aichi Medical University, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aichi Medical University, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Amano","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Aichi Medical University, Nagakute, Aichi, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2022,7,21]]},"reference":[{"key":"2025082802262331000_15.7.e249183.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.03.605"},{"key":"2025082802262331000_15.7.e249183.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9149(01)01978-6"},{"key":"2025082802262331000_15.7.e249183.3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jce.13228","article-title":"Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis","volume":"28","author":"Yalagudri","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025082802262331000_15.7.e249183.4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.hroo.2021.07.005","article-title":"Management of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"2","author":"Viwe","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"2025082802262331000_15.7.e249183.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2006.03.031"},{"key":"2025082802262331000_15.7.e249183.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2008.10.039"},{"key":"2025082802262331000_15.7.e249183.7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.302549"},{"key":"2025082802262331000_15.7.e249183.8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.929703"},{"key":"2025082802262331000_15.7.e249183.9","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/jce.13324","article-title":"Stellate ganglion blockade for the treatment of refractory ventricular arrhythmias: a systematic review and meta-analysis","volume":"28","author":"Fudim","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025082802262331000_15.7.e249183.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacep.2017.06.006"},{"key":"2025082802262331000_15.7.e249183.11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacep.2021.04.015","article-title":"Stellate ganglion phototherapy using low-level laser: a novel rescue therapy for patients with refractory ventricular arrhythmias","volume":"7","author":"Nonoguchi","year":"2021","journal-title":"JACC Clin Electrophysiol"},{"key":"2025082802262331000_15.7.e249183.12","first-page":"1977.e1","article-title":"Refractory ventricular tachycardia in a patient with a left ventricular assist device successfully treated with stellate ganglion phototherapy","volume":"36","author":"Sato","year":"2020","journal-title":"Can J Cardiol"},{"key":"2025082802262331000_15.7.e249183.13","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 Guideline on Diagnosis and Treatment of Cardiac Sarcoidosis\u3000- Digest Version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"2025082802262331000_15.7.e249183.14","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00027.2004"},{"key":"2025082802262331000_15.7.e249183.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2007.06.006"},{"key":"2025082802262331000_15.7.e249183.16","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/jce.14689","article-title":"Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: insights from implantable cardioverter-defibrillator diagnostics","volume":"31","author":"Medor","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2025082802262331000_15.7.e249183.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474X.2011.00418.x"},{"key":"2025082802262331000_15.7.e249183.18","doi-asserted-by":"publisher","DOI":"10.1007\/s00429-005-0462-1"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2022-249183","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:26:29Z","timestamp":1756373189000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2022-249183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":18,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7,21]]},"published-print":{"date-parts":[[2022,7]]}},"alternative-id":["10.1136\/bcr-2022-249183"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2022-249183","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7]]}}}